• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Lark Health Expands Weight Management Offerings to Support GLP-1 Needs

by Jasmine Pennic 09/28/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Lark Health Expands Weight Management Offerings to Support GLP-1 Needs

What You Should Know: 

– Lark Health, a conversational-AI health coaching platform for managing chronic conditions expands its weight management program to include the clinical management of GLP-1s – and taking a different approach. 

– These expanded offerings build upon Lark’s long and proven track record as one of the largest  diabetes prevention programs (DPP) and weight loss providers for health plans, ensuring personalized support for every member, regardless of where they are in their health journey. Lark’s DPP is a Centers for Disease Control and Prevention (CDC)-recognized lifestyle change program and has received Full Recognition, the CDC’s highest level of certification.

Support Guided GLP-1 Care Delivery

GLP-1 agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2 diabetes. Some GLP-1 agonists can also help treat obesity. Since GLP-1s are not right for everyone and require comprehensive support for lasting success, Lark’s unique approach to GLP-1 management includes a tailored combination of responsible clinical screening and prescribing, ongoing clinical management, and industry-leading behavior change coaching that’s available 24/7. 

As part of this approach, Lark will now offer three new programs – the Healthy Weight program, GLP-1 Companion program, and Clinician-Guided Step Therapy program – all of which leverage the sustained behavior change, lifestyle management, and remote patient monitoring Lark is known for.

●  Healthy Weight is Lark’s award-winning weight loss program that offers AI-driven holistic personalized coaching on lifestyle modification — including nutrition, physical activity, sleep, and stress — to help members lose weight and keep it off – and help employers to provide an industry-leading alternative to more expensive GLP-1 solutions.

●  GLP-1 Companion Program is our comprehensive support program for those taking GLP-1 medications. In addition to coaching on lifestyle modification, the program includes side effect management, medication adherence support, and clinical escalations as necessary.

●  Clinician-Guided Step Therapy is our program to provide access to end-to-end clinician-led therapy, offering insurance navigation, prescription management, lab monitoring, and ongoing management to ensure continuity of care.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Knowledge Hub

 How Top Health Plans Use AI to Save Money and Work Smarter How Top Health Plans Use AI to Save Money and Work Smarter

 How to Build Hybrid Care Models Around Remote Patient Monitoring How to Build Hybrid Care Models Around Remote Patient Monitoring

Trending

Clinician Shortage Worsens Primary Care Crisis, Experts Reveal

Clinician Shortage Worsens Primary Care Crisis, Experts Reveal

FDA Grants Clearance for UltraSight's AI Cardiac Ultrasound

Israel Defense Forces to Utilize UltraSight’s PoCUS Devices in Combat

The Future of Biomarker-Based Therapy for Mental Disorder Care

The Future of Biomarker-Based Therapy for Mental Disorder Care

HLTH23: 6 Digital Health Executives Share Key Takeaways

6 Digital Health Executives Share Key Takeaways from HLTH23

HIMSS Appoints New Chief Financial Officer & General Counsel

HIMSS Appoints New Chief Financial Officer & General Counsel

GoodRx Now Offers Access to $35 Insulin to All Americans

GoodRx Now Offers Access to $35 Insulin to All Americans

Ozempic: From Diabetes Management to Potential Weight Loss Miracle

Ozempic: From Diabetes Management to Potential Weight Loss Miracle

Health M&A: Financial Distress Driving Q3 Healthcare Deals

Health M&A: Financial Distress Driving Q3 Healthcare Deals

GE HealthCare Inks $44M Contract with BARDA to Develop AI-Driven Ultrasound Tech

GE HealthCare Inks $44M Contract with BARDA to Develop AI-Driven Ultrasound Tech

UnitedHealthcare Launches No Deductible Health Plan, Surest

UnitedHealthcare Launches No Deductible Health Plan, Surest

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |